Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs.
作者信息
Kyle Margaret, Williams Heidi
机构信息
MINES ParisTech (CERNA) and PSL Research University, V329, 60 boulevard Saint Michel, 75272 Paris Cedex 06 France.
Department of Economics, MIT, 50 Memorial Drive, E52-440, Cambridge MA 02142.
出版信息
Am Econ Rev. 2017 May;107(5):486-490. doi: 10.1257/aer.p20171086.
Abstract
摘要
相似文献
1
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs.美国医疗保健是否效率极低？来自处方药的证据。
Am Econ Rev. 2017 May;107(5):486-490. doi: 10.1257/aer.p20171086.
2
An international view of how recent-onset atrial fibrillation is treated in the emergency department.国际视角下的急诊科新发心房颤动的治疗方法。
Acad Emerg Med. 2012 Nov;19(11):1255-60. doi: 10.1111/acem.12016.
3
Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.与其他国家相比，美国的品牌药物价格更高，支出也更多，这可能部分源于新药的快速普及。
Health Aff (Millwood). 2013 Apr;32(4):753-61. doi: 10.1377/hlthaff.2012.0920.
4
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012.1995 - 2012年制药创新对瑞士过早癌症死亡率的影响
Eur J Health Econ. 2016 Sep;17(7):833-54. doi: 10.1007/s10198-015-0725-6. Epub 2015 Sep 5.
5
The pros and cons of generic drugs.仿制药的优缺点。
BMJ. 2011 Jul 20;343:d4584. doi: 10.1136/bmj.d4584.
6
CDC Grand Rounds: Improving medication adherence for chronic disease management - Innovations and opportunities.美国疾病控制与预防中心医学大查房：改善慢性病管理中的药物依从性——创新与机遇
Am J Transplant. 2018 Feb;18(2):514-517. doi: 10.1111/ajt.14649.
7
Ride the wave of innovation.乘创新之浪。
Health Serv J. 2009 Nov 12;119(6182):15.
8
CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management - Innovations and Opportunities.美国疾病控制与预防中心医学大查房：改善慢性病管理中的药物依从性——创新与机遇
MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1248-1251. doi: 10.15585/mmwr.mm6645a2.
9
On the need for innovation in healthcare.
Health Serv J. 2012 Nov 29;122(6331):Suppl 2.
10
Comprehensive comparison of drug prescribing in the United States and United Kingdom.美国和英国的药物处方综合比较。
Pharmacotherapy. 2011 Jul;31(7):623-9. doi: 10.1592/phco.31.7.623.
引用本文的文献
1
Access to veterinary care in Canada: a cross-sectional survey of animal healthcare organizations and interventions.加拿大的兽医护理服务：对动物保健组织及干预措施的横断面调查
Front Vet Sci. 2025 May 30;12:1581316. doi: 10.3389/fvets.2025.1581316. eCollection 2025.
2
Veterinary and pet owner perspectives on addressing access to veterinary care and workforce challenges.兽医和宠物主人对解决兽医护理可及性和劳动力挑战的看法。
Front Vet Sci. 2024 Jul 4;11:1419295. doi: 10.3389/fvets.2024.1419295. eCollection 2024.
3
Predicting health outcomes in dogs using insurance claims data.利用保险索赔数据预测犬只的健康结果。
Sci Rep. 2023 Jun 5;13(1):9122. doi: 10.1038/s41598-023-36023-5.
4
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.药物特性与药品制造商直接面向消费者的广告支出之间的关联。
JAMA. 2023 Feb 7;329(5):386-392. doi: 10.1001/jama.2022.23968.
5
Availability of New Medicines in the US and Germany From 2004 to 2018.2004 年至 2018 年美国和德国新药的供应情况。
JAMA Netw Open. 2022 Aug 1;5(8):e2229231. doi: 10.1001/jamanetworkopen.2022.29231.
6
Putting Access to Veterinary Care on the Map: A Veterinary Care Accessibility Index.让兽医护理可及性受到关注：兽医护理可及性指数
Front Vet Sci. 2022 Apr 4;9:857644. doi: 10.3389/fvets.2022.857644. eCollection 2022.
7
Critical Problems for Research in Animal Sheltering, a Conceptual Analysis.动物收容所研究中的关键问题：概念分析
Front Vet Sci. 2022 Apr 1;9:804154. doi: 10.3389/fvets.2022.804154. eCollection 2022.
8
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study.FDA 和 EMA 加速审批计划与新药的治疗价值之间的关联：回顾性队列研究。
BMJ. 2020 Oct 7;371:m3434. doi: 10.1136/bmj.m3434.
9
Companion animal models of neurological disease.神经疾病的伴侣动物模型。
J Neurosci Methods. 2020 Feb 1;331:108484. doi: 10.1016/j.jneumeth.2019.108484. Epub 2019 Nov 13.
10
Why measuring outcomes is important in health care.为何测量结果在医疗保健中很重要。
J Vet Intern Med. 2019 Mar;33(2):356-362. doi: 10.1111/jvim.15458. Epub 2019 Feb 19.
本文引用的文献
1
Patents and the Global Diffusion of New Drugs.专利与新药的全球扩散。
Am Econ Rev. 2016 Jan;106(1):136-64. doi: 10.1257/aer.20141482.
2
Is American health care uniquely inefficient?美国的医疗保健是否特别低效？
J Econ Perspect. 2008 Fall;22(4):27-50. doi: 10.1257/jep.22.4.27.
3
The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s.价格管制对新药上市延迟的影响——来自20世纪90年代25个主要市场的证据。
Health Econ. 2005 Mar;14(3):269-92. doi: 10.1002/hec.931.
Zotero 插件